Clinical Trials Browser

Phase 1/2 × Glioblastoma × azeliragon × Clear all

NCT05635734 2026-02-05

Azeliragon and Chemoradiotherapy in Newly Diagnosed Glioblastoma

Phase 1/2 Active not recruiting

Glioblastoma